Search - tctmd.com

Displaying 741 - 760 of 1167

Sort: Relevancy | Date

News Daily News

Subanálisis del Ensayo CoreValve norteamericano: Solo la TAVR Femoral Ofrece una Ventaja en la Calidad de Vida Precoz sobre la Cirugía

L.A. McKeown

August 19, 2015

News Daily News

CoreValve美国亚组分析：仅有股动脉TAVR表现出相对于外科手术的早期生活质量优势

L.A. McKeown

August 19, 2015

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

肺动脉高压磨损可预测TAVR结果，可以帮助选择潜在适合者

Yael L. Maxwell

August 05, 2015

News Daily News

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

Yael L. Maxwell

August 05, 2015

News Daily News

El Tipo de Hipertensión Pulmonar Predice el Resultado TAVR y Podría Ayudar a Seleccionar los Candidatos

Yael L. Maxwell

August 05, 2015

News Industry News

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

July 29, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

News Industry News

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

July 22, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Daily News

CTOs Relatively Frequent in Patients Without Previously Known CAD

Nicole Lou

June 30, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

Advertisement

Subanálisis del Ensayo CoreValve norteamericano: Solo la TAVR Femoral Ofrece una Ventaja en la Calidad de Vida Precoz sobre la Cirugía

CoreValve美国亚组分析：仅有股动脉TAVR表现出相对于外科手术的早期生活质量优势

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

肺动脉高压磨损可预测TAVR结果，可以帮助选择潜在适合者

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

El Tipo de Hipertensión Pulmonar Predice el Resultado TAVR y Podría Ayudar a Seleccionar los Candidatos

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

CTOs Relatively Frequent in Patients Without Previously Known CAD

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content